The interface between inflammation and coagulation in cardiovascular disease

International Journal of Inflammation

Volumn 2012, Issue , 2012, Pages

  Demetz, Gabriele ^a   Ott, Ilka ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR; PROTHROMBIN; THROMBOPLASTIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; DOWNSTREAM PROCESSING; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

EID: 84870497680     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2012/860301     Document Type: Review

References (102)

1. Aukrust P., Berge R. K., Ueland T., Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. Journal of the American College of Cardiology 2001 37 2 485 491 10.1016/S0735-1097(00) 01110-4
2. Biasucci L. M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., Rebuzzi A. G., Ciliberto G., Maseri A., Elevated levels of interleukin-6 in unstable angina. Circulation 1996 94 5 874 877 2-s2.0-0029830113 (Pubitemid 26292834)
3. Miyao Y., Yasue H., Ogawa H., Misumi I., Masuda T., Sakamoto T., Morita E., Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. American Heart Journal 1993 126 6 1299 1304 2-s2.0-0027134770 10.1016/0002-8703(93)90526-F (Pubitemid 24000023)
4. Haverkate F., Thompson S. G., Pyke S. D., Gallimore J. R., Pepys M. B., European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group, Production of C-reactive protein and risk of coronary events in stable and unstable angina. The Lancet 1997 349 9050 462 466 10.1016/S0140-6736(96) 07591-5 (Pubitemid 27077826)
5. Lagrand W. K., Visser C. A., Hermens W. T., Niessen H. W., Verheugt F. W., Wolbink G. J., Hack C. E., C-reactive protein as a cardiovascular risk factor more than an epiphenomenon? Circulation 1999 100 1 96 102 2-s2.0-0033529379 (Pubitemid 29297946)
6. Liuzzo G., Biasucci L. M., Gallimore J. R., Grillo R. L., Rebuzzi A. G., Pepys M. B., Maseri A., The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. New England Journal of Medicine 1994 331 7 417 424 2-s2.0-0027933081 10.1056/NEJM199408183310701 (Pubitemid 24247397)
7. Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L., Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. New England Journal of Medicine 2000 343 16 1139 1147
8. Lindmark E., Diderholm E., Wallentin L., Siegbahn A., Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. Journal of the American Medical Association 2001 286 17 2107 2113 2-s2.0-0035824178 (Pubitemid 34041595)
9. Morrow D. A., Rifai N., Antman E. M., C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Journal of the American College of Cardiology 1998 31 7 1460 1465 10.1016/S0735-1097(98)00136-3 (Pubitemid 28273285)
10. Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine 1997 336 14 973 979 2-s2.0-0030956673 10.1056/NEJM199704033361401 (Pubitemid 27152782)
11. Ridker P. M., Hennekens C. H., Buring J. E., Rifai N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine 2000 342 12 836 843 2-s2.0-0034704893 10.1056/NEJM200003233421202 (Pubitemid 30165206)
12. Ridker P. M., Rifai N., Stampfer M. J., Hennekens C. H., Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000 101 15 1767 1772 2-s2.0-0034681920 (Pubitemid 30213096)
13. Dibra A., Mehilli J., Schwaiger M., Schühlen H., Bollwein H., Braun S., Neverve J., Schömig A., Kastrati A., Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. European Heart Journal 2003 24 12 1128 1133 2-s2.0-0038613631 10.1016/S0195-668X(03)00200-8 (Pubitemid 36723578)
14. Barrett T. D., Hennan J. K., Marks R. M., Lucchesi B. R., C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion. Journal of Pharmacology and Experimental Therapeutics 2002 303 3 1007 1013 2-s2.0-0036896917 10.1124/jpet.102.040600 (Pubitemid 35424383)
15. Yamasaki Y., Matsuo Y., Matsuura N., Onodera H., Itoyama Y., Kogure K., Feuerstein G. Z., Transient increase of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in ischemic brain areas after focal ischemia in rats. Stroke 1995 26 2 318 323 2-s2.0-0028853977
16. Gerszten R. E., Garcia-Zepeda E. A., Lim Y. C., Yoshida M., Ding H. A., Gimbrone M. A. Jr., Luster A. D., Luscinskas F. W., Rosenzwelg A., MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999 398 6729 718 723 2-s2.0-0033594416 10.1038/19546 (Pubitemid 29197651)
17. Dinarello C. A., Gelfand J. A., Wolff S. M., Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. Journal of the American Medical Association 1993 269 14 1829 1835 2-s2.0-0027528798 10.1001/jama.269.14.1829 (Pubitemid 23097351)
18. Boisvert W. A., Santiago R., Curtiss L. K., Terkeltaub R. A., A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor- deficient mice. Journal of Clinical Investigation 1998 101 2 353 363 2-s2.0-0032518420 (Pubitemid 28067332)
19. Leek R. D., Landers R., Fox S. B., Ng F., Harris A. L., Lewis C. E., Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. British Journal of Cancer 1998 77 12 2246 2251 2-s2.0-0031800372 (Pubitemid 28263948)
20. Yudkin J. S., Kumari M., Humphries S. E., Mohamed-Ali V., Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000 148 2 209 214 2-s2.0-0033984744 10.1016/S0021-9150(99) 00463-3 (Pubitemid 30064452)
21. Ikeda U., Ikeda M., Oohara T., Oguchi A., Kamitani T., Tsuruya Y., Kano S., Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. American Journal of PhysiologyHeart and Circulatory Physiology 1991 260 5, part 2 H1713 H1717 2-s2.0-0025892584
22. Steppich B. A., Moog P., Matissek C., Wisniowski N., Kühle J., Joghetaei N., Neumann F. J., Schomig A., Ott I., Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 2007 190 2 443 451 2-s2.0-33846093007 10.1016/j.atherosclerosis.2006.02.034 (Pubitemid 46074036)
23. Lipinski S., Bremer L., Lammers T., Thieme F., Schreiber S., Rosenstiel P., Coagulation and inflammation. Molecular insights and diagnostic implications. Hamostaseologie 2011 31 2 94 104
24. Ott I., Soluble tissue factor emerges from inflammation. Circulation Research 2005 96 12 1217 1218 2-s2.0-21844450200 10.1161/01.RES.0000172745. 09928.87 (Pubitemid 40962097)
25. Ardissino D., Merlini P. A., Gamba G., Barberis P., Demicheli G., Testa S., Colombi E., Poli A., Fetiveau R., Montemartini C., Thrombin activity and early outcome in unstable angina pectoris. Circulation 1996 93 9 1634 1639 2-s2.0-0029664361
26. Ernofsson M., Strekerud F., Toss H., Abildgaard U., Wallentin L., Siegbahn A., Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease. Thrombosis and Haemostasis 1998 79 3 491 494 2-s2.0-0031888017 (Pubitemid 28120777)
27. Moss A. J., Goldstein R. E., Marder V. J., Sparks C. E., Oakes D., Greenberg H., Weiss H. J., Zareba W., Brown M. W., Liang C. S., Lichstein E., Little W. C., Gillespie J. A., van Voorhees L., Krone R. J., Bodenheimer M. M., Hochman J., Dwyer E. M. Jr., Arora R., Marcus F. I., Watelet L. F. M., Case R. B., Thrombogenic factors and recurrent coronary events. Circulation 1999 99 19 2517 2522 2-s2.0-0033580591 (Pubitemid 29228281)
28. Mackman N., Regulation of the tissue factor gene. The Journal of the Federation of American Societies for Experimental Biology 1995 9 10 883 889 2-s2.0-0029100932
29. Neumann F. J., Ott I., Marx N., Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arteriosclerosis, Thrombosis, and Vascular Biology 1997 17 12 3399 3405 10.1161/01.ATV.17.12.3399 (Pubitemid 28028548)
30. Hatakeyama K., Asada Y., Marutsuka K., Sato Y., Kamikubo Y., Sumiyoshi A., Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997 133 2 213 219 2-s2.0-0030771847 10.1016/S0021-9150(97)00132-9 (Pubitemid 27373498)
31. Wilcox J. N., Smith K. M., Schwartz S. M., Gordon D., Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proceedings of the National Academy of Sciences of the United States of America 1989 86 8 2839 2843 2-s2.0-0001495165 (Pubitemid 19112635)
32. Mallat Z., Benamer H., Hugel B., Benessiano J., Steg P. G., Freyssinet J. M., Tedgui A., Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000 101 8 841 843 2-s2.0-0033999142 (Pubitemid 30117876)
33. Ott I., Andrassy M., Zieglgänsberger D., Geith S., Schömig A., Neumann F. J., Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001 97 12 3721 3726 2-s2.0-0035878011 10.1182/blood.V97.12.3721
34. Ott I., Neumann F. J., Kenngott S., Gawaz M., Schömig A., Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. American Journal of Cardiology 1998 82 8 938 942 2-s2.0-0032532410 10.1016/S0002-9149(98)00509-8 (Pubitemid 28480778)
35. Bogdanov V. Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., Nemerson Y., Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nature Medicine 2003 9 4 458 462 2-s2.0-0037391809 10.1038/nm841 (Pubitemid 36460081)
36. Szotowski B., Antoniak S., Poller W., Schultheiss H. P., Rauch U., Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circulation Research 2005 96 12 1233 1239 2-s2.0-21844455249 10.1161/01.RES.0000171805.24799.fa (Pubitemid 40962100)
37. Giesen P. L., Rauch U., Bohrmann B., Kling D., Roqué M., Fallon J. T., Badimon J. J., Himber J., Riederer M. A., Nemerson Y., Blood-borne tissue factor: another view of thrombosis. Proceedings of the National Academy of Sciences of the United States of America 1999 96 5 2311 2315 2-s2.0-13044304178 10.1073/pnas.96.5.2311 (Pubitemid 29117911)
38. Misumi K., Ogawa H., Yasue H., Soejima H., Suefuji H., Nishiyama K., Takazoe K., Kugiyama K., Tsuji I., Kumeda K., Nakamura S., Comparison of plasma tissue factor levels in unstable and stable angina pectoris. American Journal of Cardiology 1998 81 1 22 26 2-s2.0-0031973874 10.1016/S0002-9149(97)00801-1 (Pubitemid 28046836)
39. Soejima H., Ogawa H., Yasue H., Suefuji H., Kaikita K., Nishiyama K., Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction. Clinical Cardiology 1997 20 5 441 445 10.1002/clc.4960200507 (Pubitemid 27184937)
40. Falciani M., Gori A. M., Fedi S., Chiarugi L., Simonetti I., Dabizzi R. P., Prisco D., Pepe G., Abbate R., Gensini G. F., Serneri G. G. N., Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thrombosis and Haemostasis 1998 79 3 495 499 2-s2.0-0031888802 (Pubitemid 28120778)
41. Sakai T., Inoue S., Takei M., Activated inflammatory cells participate in thrombus size through tissue factor and plasminogen activator inhibitor-1 in acute coronary syndrome: immunohistochemical analysis. Thrombosis Research 2011 127 5 443 449 10.1016/j.thromres.2011.02.001
42. Bis J., Vojáček J., Dušek J., Time-course of tissue factor plasma level in patients with acute coronary syndrome. Physiological Research 2009 58 5 661 667
43. Andrié R. P., Bauriedel G., Braun P., Höpp H. W., Nickenig G., Skowasch D., Increased expression of C-reactive protein and tissue factor in acute coronary syndrome lesions. Correlation with serum C-reactive protein, angioscopic findings, and modification by statins. Atherosclerosis 2009 202 1 135 143 2-s2.0-57649155345 10.1016/j.atherosclerosis.2008.03.028
44. Malarstig A., Tenno T., Johnston N., Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 12 2667 2672 10.1161/01.ATV.0000191637.48129.9b (Pubitemid 43732295)
45. Maly M., Vojacek J., Hrabos V., Kvasnicka J., Salaj P., Durdil V., Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome. Physiological Research 2003 52 6 719 728 (Pubitemid 38090101)
46. Morange P. E., Alessi M. C., Juhan-Vague I., Relations between hemostatic variables, insulin resistance and inflammation. Hematology Journal 2004 5 supplement 3 S15 S19 2-s2.0-4043064980 10.1038/sj.thj.6200415 (Pubitemid 39077267)
47. Morange P. E., Bickel C., Nicaud V., Schnabel R., Rupprecht H. J., Peetz D., Lackner K. J., Cambien F., Blankenberg S., Tiret L., Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 12 2793 2799 2-s2.0-33751192457 10.1161/01.ATV.0000249406.92992.0d
48. Steppich B. A., Braun S. L., Stein A., Demetz G., Groha P., Schömig A., von Beckerath N., Kastrati A., Ott I., Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction. Thrombosis Journal 2009 7, article no. 11 2-s2.0-68249146068 10.1186/1477-9560-7-11
49. Erlich J. H., Boyle E. M., Labriola J., Kovacich J. C., Santucci R. A., Fearns C., Morgan E. N., Yun W., Luther T., Kojikawa O., Martin T. R., Pohlman T. H., Verrier E. D., Mackman N., Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. American Journal of Pathology 2000 157 6 1849 1862 2-s2.0-0033639115
50. Ott I., Michaelis C., Schuermann M., Steppich B., Seitz I., Dewerchin M., Zohlnhofer D., Wessely R., Rudelius M., Schömig A., Carmeliet P., Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circulation Research 2005 97 3 293 298 2-s2.0-23344448867 10.1161/01.RES.0000177533.48483. 12 (Pubitemid 41105456)
51. Rickles F. R., Hair G. A., Zeff R. A., Lee E., Bona R. D., Tissue factor expression in human leukocytes and tumor cells. Thrombosis and Haemostasis 1995 74 1 391 395 2-s2.0-0029161842
52. White R. H., Chew H., Wun T., Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk? Thrombosis Research 2007 120 supplement 2 S29 S40 2-s2.0-36048936310 10.1016/S0049-3848(07) 70128-7 (Pubitemid 350101771)
53. Mueller B. M., Reisfeld R. A., Edgington T. S., Ruf W., Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proceedings of the National Academy of Sciences of the United States of America 1992 89 24 11832 11836 2-s2.0-0027071674 10.1073/pnas.89.24.11832 (Pubitemid 23004738)
54. Yu J. L., May L., Lhotak V., Shahrzad S., Shirasawa S., Weitz J. I., Coomber B. L., Mackman N., Rak J. W., Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005 105 4 1734 1741 2-s2.0-13544256266 10.1182/blood-2004- 05-2042 (Pubitemid 40223697)
55. Ott I., Weigand B., Michl R., Seitz I., Sabbari-Erfani N., Neumann F. J., Schömig A., Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation 2005 111 3 349 355 2-s2.0-12844283269 10.1161/01.CIR.0000153333. 52294.42 (Pubitemid 40165343)
56. Ettelaie C., Li C., Collier M. E., Pradier A., Frentzou G. A., Wood C. G., Chetter I. C., McCollum P. T., Bruckdorfer K. R., James N. J., Differential functions of tissue factor in the trans-activation of cellular signalling pathways. Atherosclerosis 2007 194 1 88 101 2-s2.0-34848915475 10.1016/j.atherosclerosis.2006.10.010 (Pubitemid 47495924)
57. Iversen N., Lindahl A. K., Abildgaard U., Elevated plasma levels of the factor Xa-TFPI complex in cancer patients. Thrombosis Research 2002 105 1 33 36 2-s2.0-0036180014 10.1016/S0049-3848(01)00404-2 (Pubitemid 34178305)
58. Ott I., Malcouvier V., Schömig A., Neumann F. J., Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction. Circulation 2002 105 3 279 281 2-s2.0-0037154305 10.1161/hc0302.103591 (Pubitemid 34106171)
59. Massberg S., Grahl L., von Bruehl M. L., Manukyan D., Pfeiler S., Goosmann C., Brinkmann V., Lorenz M., Bidzhekov K., Khandagale A. B., Konrad I., Kennerknecht E., Reges K., Holdenrieder S., Braun S., Reinhardt C., Spannagl M., Preissner K. T., Engelmann B., Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nature Medicine 2010 16 8 887 896 2-s2.0-77955410626 10.1038/nm.2184
60. Busch G., Seitz I., Steppich B., Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 2 461 466 10.1161/01.ATV.0000151279.35780.2d (Pubitemid 40189174)
61. Schaffner A., Rhyn P., Schoedon G., Schaer D. J., Regulated expression of platelet factor 4 in human monocytesrole of PARs as a quantitatively important monocyte activation pathway. Journal of Leukocyte Biology 2005 78 1 202 209 2-s2.0-22144494616 10.1189/jlb.0105024 (Pubitemid 40979959)
62. Seitz I., Hess S., Schulz H., Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 4 769 775 10.1161/01.ATV.0000258862.61067.14 (Pubitemid 46606705)
63. Napoli C., de Nigris F., Wallace J. L., Hollenberg M. D., Tajana G., de Rosa G., Sica V., Cirino G., Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. Journal of Clinical Pathology 2004 57 5 513 516 2-s2.0-2442507928 10.1136/jcp.2003.015156 (Pubitemid 38621797)
64. van der Poll T., Boer J. D., Levi M., The effect of inflammation on coagulation and vice versa. Current Opinion in Infectious Diseases 2011 24 3 273 278 10.1097/QCO.0b013e328344c078
65. Danese S., Vetrano S., Zhang L., Poplis V. A., Castellino F. J., The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. Blood 2009 115 6 1121 1131 2-s2.0-77949515745 10.1182/blood-2009-09-201616
66. Ruf W., Dorfleutner A., Riewald M., Specificity of coagulation factor signaling. Journal of Thrombosis and Haemostasis 2003 1 7 1495 1503 2-s2.0-0141498162
67. Niessen F., Furlan-Freguia C., Fernández J. A., Mosnier L. O., Castellino F. J., Weiler H., Rosen H., Griffin J. H., Ruf W., Endogenous EPCR/aPC-PARI signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009 113 12 2859 2866 2-s2.0-63849278353 10.1182/blood-2008-12- 192385
68. Kerschen E. J., Fernandez J. A., Cooley B. C., Yang X. V., Sood R., Mosnier L. O., Castellino F. J., Mackman N., Griffin J. H., Weiler H., Endotoxemia and sepsis mortality reduction by non-anticoagulant-activated protein C. Journal of Experimental Medicine 2007 204 10 2439 2448 2-s2.0-34948866150 10.1084/jem.20070404 (Pubitemid 47529328)
69. Cao C., Gao Y., Li Y., Antalis T. M., Castellino F. J., Zhang L., The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. Journal of Clinical Investigation 2010 120 6 1971 1980 2-s2.0-77953202368 10.1172/JCI40380
70. Brass L. F., Thrombin and platelet activation. Chest 2003 124 supplement 3 18S 25S 2-s2.0-0141484537 10.1378/chest.124.3suppl.18S (Pubitemid 37128432)
71. Senden N. H., Jeunhomme T. M., Heemskerk J. W., Wagenvoord R., van't Veer C., Hemker H. C., Buurman W. A., Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. Journal of Immunology 1998 161 8 4318 4324 2-s2.0-0032531987 (Pubitemid 28469016)
72. Macfarlane S. R., Seatter M. J., Kanke T., Hunter G. D., Plevin R., Proteinase-activated receptors. Pharmacological Reviews 2001 53 2 245 282 2-s2.0-0035019636 (Pubitemid 32476117)
73. Gouin-Thibault I., Dewar L., Craven S., Kulczycky M., Wun T. C., Ofosu F. A., Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo. British Journal of Haematology 1996 95 4 738 746 2-s2.0-0030445026 (Pubitemid 26423381)
74. Ohkura N., Soe G., Kohno I., Kumeda K., Wada H., Kamikubo Y., Shiku H., Kato H., Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation. Blood Coagulation and Fibrinolysis 1999 10 6 309 319 2-s2.0-0032834614 (Pubitemid 29416075)
75. Collins R., Peto R., Baigent C., Sleight P., Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. New England Journal of Medicine 1997 336 12 847 860 2-s2.0-0030893793 10.1056/ NEJM199703203361207 (Pubitemid 27132984)
76. The Direct Thrombin Inhibitor Trialists' Collaborative Group, Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. The Lancet 2002 359 9303 294 302 2-s2.0-0037176525 10.1016/S0140-6736(02)07495-0 (Pubitemid 34119293)
77. The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators, Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. The Lancet 2001 358 9282 605 613 2-s2.0-0035949117 10.1016/S0140-6736(01)05775-0 (Pubitemid 32786824)
78. Yusuf S., Mehta S. R., Chrolavicius S., Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. The Journal of the American Medical Association 2006 295 13 1519 1530 10.1001/jama.295.13.joc60038
79. Gibson C. M., Mega J. L., Burton P., Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome. American Heart Journal 2011 161 5 815 821.e6 10.1016/j.ahj.2011.01.026
80. Camerer E., Kataoka H., Kahn M., Lease K., Coughlin S. R., Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. Journal of Biological Chemistry 2002 277 18 16081 16087 2-s2.0-0037013268 10.1074/jbc.M108555200 (Pubitemid 34967893)
81. Riewald M., Kravchenko V. V., Petrovan R. J., O'Brien P. J., Brass L. F., Ulevitch R. J., Ruf W., Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 2001 97 10 3109 3116 2-s2.0-0035874536 10.1182/blood.V97.10.3109
82. Demetz G., Seitz I., Stein A., Steppich B., Groha P., Brandl R., Schömig A., Ott I., Tissue factor-factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells. Atherosclerosis 2010 212 2 466 471 2-s2.0-77957721987 10.1016/j.atherosclerosis.2010.07.017
83. Hjortoe G. M., Petersen L. C., Albrektsen T., Sorensen B. B., Norby P. L., Manda S. K., Pendurthi U. R., Rao L. V., Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004 103 8 3029 3037 2-s2.0-1842474888 10.1182/blood-2003-10-3417 (Pubitemid 38451676)
84. Moons A. H., Levi M., Peters R. J., Tissue factor and coronary artery disease. Cardiovascular Research 2002 53 2 313 325 2-s2.0-0036159583 10.1016/S0008-6363(01)00452-7 (Pubitemid 34117681)
85. Koizume S., Jin M. S., Miyagi E., Hirahara F., Nakamura Y., Piao J. H., Asai A., Yoshida A., Tsuchiya E., Ruf W., Miyagi Y., Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Research 2006 66 19 9453 9460 2-s2.0-33750286014 10.1158/0008-5472.CAN-06-1803 (Pubitemid 44623642)
86. Schaffner F., Ruf W., Tissue factor and PAR2 signaling in the tumor microenvironment. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 12 1999 2004 2-s2.0-73849102545 10.1161/ATVBAHA.108.177428
87. Gessler F., Voss V., Dützmann S., Seifert V., Gerlach R., Kögel D., Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience 2010 165 4 1312 1322 10.1016/j.neuroscience.2009.11.049
88. Zerbib P., Grimonprez A., Corseaux D., Mouquet F., Nunes B., Petersen L. C., Susen S., Ung A., Hebbar M., Pruvot F. R., Chambon J. P., Jude B., Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer. Journal of Surgical Research 2009 153 2 239 245 2-s2.0-64849097008 10.1016/j.jss.2008.05.014
89. Hinshaw L. B., Emerson T. E. Jr., Chang A. C., Duerr M., Peer G., Fournel M., Study of septic shock in the non-human primate: relationship of pathophysiological response to therapy with anti-TNF antibody. Circulatory Shock 1994 44 4 221 229 2-s2.0-0028673544
90. Hinshaw L. B., Emerson T. E. Jr., Taylor F. B. Jr., Chang A. C., Duerr M., Peer G. T., Flournoy D. J., White G. L., Kosanke S. D., Murray C. K., Xu R., Passey R. B., Fournel M. A., Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. Journal of Trauma 1992 33 4 568 573 2-s2.0-0026481128
91. Hinshaw L. B., Tekamp-Olson P., Chang A. C., Lee P. A., Taylor F. B. Jr., Murray C. K., Peer G. T., Emerson T. E. Jr., Passey R. B., Kuo G. C., Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Circulatory Shock 1990 30 3 279 292 2-s2.0-0025193590 (Pubitemid 20116728)
92. Clark M. A., Plank L. D., Connolly A. B., Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsisa randomized, clinical trial. Critical Care Medicine 1998 26 10 1650 1659 (Pubitemid 28467672)
93. Favalli E. G., Desiati F., Atzeni F., Sarzi-Puttini P., Caporali R., Pallavicini F. B., Gorla R., Filippini M., Marchesoni A., Serious infections during anti-TNF α treatment in rheumatoid arthritis patients. Autoimmunity Reviews 2009 8 3 266 273 2-s2.0-58749090375 10.1016/j.autrev.2008.11.002
94. Goode S., Tierney G., Deighton C., Life threatening intra-abdominal sepsis in patients on anti-TNF- α therapy. Gut 2006 55 4 590 591 2-s2.0-33645126747 10.1136/gut.2005.085449
95. Ho G. T., Mowat A., Potts L., Cahill A., Mowat C., Lees C. W., Hare N. C., Wilson J. A., Boulton-Jones R., Priest M., Watts D. A., Shand A. G., Arnott I. D., Russell R. K., Wilson D. C., Morris A. J., Satsangi J., Efficacy and complications of adalimumab treatment for medically-refractory Crohn's disease: analysis of nationwide experience in Scotland (20042008). Alimentary Pharmacology and Therapeutics 2009 29 5 527 534 2-s2.0-59249106670 10.1111/j.1365-2036.2008.03919.x
96. Levi M., van der Poll T., Büller H. R., Bidirectional relation between inflammation and coagulation. Circulation 2004 109 22 2698 2704 2-s2.0-2942545798 10.1161/01.CIR.0000131660.51520.9A (Pubitemid 38737913)
97. Carr C., Bild G. S., Chang A. C., Peer G. T., Palmier M. O., Frazier R. B., Gustafson M. E., Wun T. C., Creasey A. A., Hinshaw L. B., Taylor F. B., Galluppi G. R., Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circulatory Shock 1994 44 3 126 137 2-s2.0-0028627767
98. Hisama N., Yamaguchi Y., Okajima K., Uchiba M., Murakami K., Mori K., Yamada S., Ogawa M., Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver. Digestive Diseases and Sciences 1996 41 7 1481 1486 2-s2.0-0030057238 10.1007/BF02088576 (Pubitemid 26245932)
99. Giugliano G. R., Giugliano R. P., Gibson C. M., Kuntz R. E., Meta-analysis of corticosteroid treatment in acute myocardial infarction. American Journal of Cardiology 2003 91 9 1055 1059 2-s2.0-0037406233 10.1016/S0002-9149(03)00148-6 (Pubitemid 36514919)
100. Antman E. M., McCabe C. H., Gurfinkel E. P., Turpie A. G., Bernink P. J., Salein D., Bayes de Luna A., Fox K., Lablanche J. M., Radley D., Premmereur J., Braunwald E., Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999 100 15 1593 1601 2-s2.0-0032870952 (Pubitemid 29477267)
101. Manduteanu I., Voinea M., Capraru M., Dragomir E., Simionescu M., A novel attribute of enoxaparin: inhibition of monocyte adhesion to endothelial cells by a mechanism involving cell adhesion molecules. Pharmacology 2002 65 1 32 37 2-s2.0-0036126383 10.1159/000056183 (Pubitemid 34233917)
102. Montalescot G., Bal-dit-Sollier C., Chibedi D., Collet J. P., Soulat T., Dalby M., Choussat R., Cohen A., Slama M., Steg P. G., Dubois-Randé J. L., Metzger J. P., Tarragano F., Guermonprez J. L., Drouet L., Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study). American Journal of Cardiology 2003 91 8 925 930 2-s2.0-0037446207 10.1016/S0002-9149(03)00105-X (Pubitemid 36398522)